Literature DB >> 25340261

Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria.

Zulfiqar Ali1, Neeraj Mishra1, Ashish Baldi1.   

Abstract

The purpose of the present work is to improve the antimalarial activity of the drug arteether (AE) by enhancing its solubility, by loading it into a nanostructured lipid carrier (NLC). The in vitro drug release profile of the NLC showed 93% drug release in 32 h. Complete eradication of the parasite from the blood and efficient anti-malarial pharmacological activity were observed, with the use of AE-loaded NLCs. These results suggest that nanolipid carriers of AE could be a promising carrier system to deliver the poorly soluble antimalarial drug through the oral route, by enhancing its solubility as well as preventing its degradation in the stomach.

Entities:  

Keywords:  antimalarial activity; arteether; in vivo studies; nanolipid carrier; solubility

Mesh:

Substances:

Year:  2014        PMID: 25340261     DOI: 10.3109/21691401.2014.968821

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  2 in total

1.  In silico analysis for factors affecting anti-malarial penetration into red blood cells.

Authors:  Natapol Pornputtapong; Bovornpat Suriyapakorn; Anchisa Satayamapakorn; Kanidsorn Larpadisorn; Pariyachut Janviriyakul; Phisit Khemawoot
Journal:  Malar J       Date:  2020-06-23       Impact factor: 2.979

Review 2.  Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria.

Authors:  Lohitha Gujjari; Hamed Kalani; Sai Kiran Pindiprolu; Bhanu Prakash Arakareddy; Ganesh Yadagiri
Journal:  Parasite Epidemiol Control       Date:  2022-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.